| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |